Pharmaceutical products
Original notice title
Germany-Hamburg: Pharmaceutical products
Opportunity Score
Why this score?
Opportunity
80 / 100
Complexity
30 / 100
Risk factors
The procedure is explicitly not a public procurement, so no challenge rights under EU procurement directives.
No guaranteed volume; discount contracts may not generate sufficient revenue.
No procurement documents available
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Supplies contract
- 3 lots
- Conclusion of non-exclusive discount agreements on pharmaceutical products under §130a Abs. 8 SGB V.
- Covering specific active substances, combinations, dosage forms, and strengths as per each lot.
Show full summary
Open House procedure by German health insurers (Techniker Krankenkasse, HEK, hkk) for non-exclusive discount agreements on pharmaceutical products (Rabattverträge nach §130a Abs. 8 SGB V). Not a public procurement under EU directives. Continuous joining possible until 31.10.2026. 10 lots for specific active substances. Award to all qualified pharmaceutical entrepreneurs.
Risks
The procedure is explicitly not a public procurement, so no challenge rights under EU procurement directives.
No guaranteed volume; discount contracts may not generate sufficient revenue.
No procurement documents available
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Bidder must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) within the meaning of §4 Abs. 18 AMG.
Administrative
- Acceptance of uniform contract conditions without negotiation.
- Submission of self-declaration on authorization and reliability.
Buyer
Name
Beschaffer: Bundesministerium für Wirtschaft und Energie (BMWE), Beschafftungsdienstleister: Forschungszentrum Jülich GmbH, Projektträger Jülich (PtJ)
Location
Karlsruhe, DEU
Website
Activity
Defence
Lots (3)
01
Carbamazepin (RET, N1, N2, N3)_TK, HEK, hkk
Non-exclusive discount agreement for Carbamazepin (retard). Insurers: TK, HEK, hkk. Excluded from substitution under AM-RL Anlage VII Teil B.
Category
Deadline
02
Ciclosporin (WKA)_TK, HEK, hkk
Non-exclusive discount agreement for Ciclosporin (Wirkstoffkombinationen). Insurers: TK, HEK, hkk. Substitution exclusion applies.
Category
Deadline
03
Levothyroxin natrium (ausgenommen WKA, LSE, TRO, ILO)_TK
Non-exclusive discount agreement for Levothyroxin sodium (excluding certain forms). Insurer: TK only. Substitution exclusion applies.
Category
Deadline
Procurement Details
- Publication date
- 19 Sep 2023
- Notice type
- Contract notice — standard
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 566780-2023
Similar tenders
Estonia – Underwear – Termopesu ostmine
Poland – Hire of industrial vehicles with driver – Kompleksowa obsługa placów składowych i transportu wewnętrznego na powierzchni (w tym kopalnianych sieci kolei wąskotorowych) na rzecz Polskiej Grupy Górniczej S.A. KWK Murcki - Staszic
France – Development services of real estate – SELECTION D'UN PROJET POUR LA REALISATION D'UN ENSEMBLE IMMOBILIER DE 28 LOGEMENTS COLLECTIFS A CHATENAY-MALABRY (92) EN CPI
Poland – Pipeline, piping, pipes, casing, tubing and related items – „Dostawy rur z tworzyw sztucznych dla Południowego Koncernu Węglowego S.A.”
Austria – Construction supervision services – A01 GEN Knoten Linz – Knoten Haid + A01 ASt Traun/Haid - Örtliche Bauaufsicht E&M
Czechia – Diagnostic agents – Dodávky ZP_IVD – Reagencie a spotřební materiál pro sekvenační analýzu
Opportunity Score
Why this score?
Opportunity
80 / 100
Complexity
30 / 100
Risk factors
The procedure is explicitly not a public procurement, so no challenge rights under EU procurement directives.
No guaranteed volume; discount contracts may not generate sufficient revenue.
No procurement documents available
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications